TISSUE APPROXIMATION SYSTEM (TAS), Models T-4000, T-5000, T-LAP Recall
TISSUE APPROXIMATION SYSTEM (TAS), Models T-4000, T-5000, T-LAP
FDA recall Class II
Ongoing
FDA lists this Class II recall for TISSUE APPROXIMATION SYSTEM (TAS), Models T-4000, T-5000, T-LAP. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1294-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jan 27, 2025
- FDA report date
- Mar 12, 2025
- Quantity in commerce
- 114
- Distribution
- See key details
- FDA cause
- Device Design
What is being recalled?
TISSUE APPROXIMATION SYSTEM (TAS), Models T-4000, T-5000, T-LAP
Affected model & UDI checker
Search the exact identifiers published for Z-1294-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| T-4000 | TISSUE APPROXIMATION SYSTEM (TAS), Models T-4000, T-5000, T-LAP | Check source notice | Not specified |
FDA code information
Model/UDI-DI/Lot(Expiration): T-4000/00197644217267/230403(2024/04/20); T-5000/00860011435921/240801(2025/08/28), 240901(2025/09/25); T-LAP/00860011435914, 00197644927241/240702(2025/07/08), 230906(2024/11/29), 230905(2024/11/29)
Why was this product recalled?
Tissue approximation straps (zip-ties) have broken before or during implantation so firm developed an interim zip-tie conditioning method submerging zip-ties in 104-degrees F sterile saline solution for 60 min prior to implantation to rehydrate the zip-tie straps. Broken zip-ties not observed during procedure could lead to future hernia recurrence, recurrent surgery to correct a large herniation.
What actions did Tas Medical, Inc. take?
On 1/27/2025, correction notices were emailed to customers who were asked to do the following: 1) Firm has developed and validated an interim method for conditioning the product in the surgical suite just prior to implantation to rehydrate the zip-tie straps per these instructions. To reverse the effects of dehydration, when preparing for surgery, submerge the TAS zip-tie straps in 40-degreesC (104-degrees F) sterile saline solution for 60 minutes prior to implantation. The orange leader material is not subject to dehydration and therefore is not required to be soaked. 2) Quarantine affected devices and insert the rehydration procedure into each of the remaining product boxes in your inventory at which point it can be released from quarantine. 3) Firm is is in the process of redesigning its packaging to prevent dehydration of the straps and will let you know when the new packaging is available. We anticipate that it may take up to six months to redesign the packaging, validate it, and release it to the field. Until then, the above rehydration procedure will restore the hydration to the straps in the surgical suite thereby preventing breakage that has been seen in the field. 4) Complete and return the acknowledgement and receipt form via email to tkramer@tasmedical.net Questions can be directed to the firm at (716) 997-2896 Monday through Friday between the hours of 8am and 5pm, EST.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1294-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology